RESOURCES | Cannabis Securities News

Cannabis-Related Securities | Weekly Update | January 16 - 22, 2023
Published on January 24, 2023

CRB Monitor Securities Database Updates

During the week of January 16 - 22, 2023, CRB Monitor’s research team made several updates to securities’ information and added source documents & relevant news articles to the CRB Monitor database.

Summary of the updates for the Week of January 16 - 22, 2023:

Tier

Total #

Active / Inactive / Pre-IPO

Added

Removed

Net Change

Tier 1A

152

128 / 22 / 2

+0 -0 +0

Tier 1B

727

591 / 134 / 2

+2 -0 +2

Tier 2

350

325 / 22 / 3

+0 -3 -3

Tier 3

515

486 / 28 / 1

+0 -0 +0

Total Issuances

1,744

1,530 / 206 / 8

+2 -3 -1

Total Issuers   (w/o Pre-IPOs)

1,310

-

+2 -1 +1

Total Issuers    (w/ Pre-IPOs)

1,318

-

+2 -1 +1

  • Added 2 Tier 1B Securities:
    • +1 = New CRB: (“AAP, Inc.”)
    • +1 = New CRB: (“Cantourage Group SE”)
  • Removed 3 Tier 2 Securities:
    • -3 = Discarded Business Record from Database: (“Tuscan Holdings Corp. II”) - 1 Issuer with 3 Securities (1 Common, 1 Warrant & 1 Unit)
      • Rationale = Tuscan Holdings Corp. II, was a blank check company (SPAC) formed to complete a transaction within the cannabis industry. However, the company failed to complete any transaction by its deadline of December 2022. As a result, the company has been delisted from NASDAQ and no longer trades. Tuscan Holdings Corp. II has commenced the process of dissolving and liquidating.

All newly-identified CRBs during the week:

Company Name

Tier

Pure-Play Sector

Description

AAP, Inc.

(OTC Pink: AAPJ)

1B Yes Owner/ Investor AAP, Inc. is a US-based company committed to exploring and investing in opportunities with advanced business models. AAP acquired a controlling interest in the Buddha Company, a Los Angeles based cannabis business. The Buddha Company has highly desirable licenses that allow for all commercial cannabis activities at one location that include: cultivation, manufacturing, retail delivery, retail storefront, and B2B distribution.

Cantourage Group SE

(FRA: HIGH)

1B Yes Owner/ Investor Cantourage Group SE is a publicly listed, leading European medical cannabis company. The Berlin-based company enables producers from all over the world to become part of the rapidly growing European medical cannabis market in a faster and more cost-effective way, while guaranteeing and developing the highest European quality standards. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol. The company indirectly holds a cannabis license in Germany through its subsidiary Cantourage GmbH.

 

Most Popular

Subscribe For Updates

Explore how CRBMonitor can simplify your cannabis-related compliance challenges.